GlassScriptPhysician profile
Cydnee Parris
NPI 1881336410
$1,652.75
in general payments reported to CMS, 2019-2025
18 companies · $520 in 2025
The $520 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $480 · 2024: $517 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,517.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $308.51 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $263.13 | 2022-2025 | Opsumit, Uptravi |
| Abbvie INC. | $143.95 | 2023-2025 | |
| Insmed, INC. | $137.17 | 2023-2025 | Arikayce |
| United Therapeutics Corporation | $109.13 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Takeda Pharmaceuticals U.S.A., INC. | $108.20 | 2024-2025 | Aralast |
| Astellas Pharma US INC | $105.87 | 2022-2025 | Cresemba |
| Glaxosmithkline, LLC. | $100.91 | 2025 | Nucala |
| Grifols USA, LLC | $76.48 | 2023-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $49.32 | 2024-2025 | Winrevair |
| Genzyme Corporation | $42.48 | 2023 | |
| Pharming Healthcare, INC. | $37.40 | 2023-2024 | Ruconest |
| Astrazeneca Pharmaceuticals LP | $36.91 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $33.62 | 2024 | Dupixent |
| Pfizer INC. | $30.70 | 2023-2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.23 | 2025 | Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $23.29 | 2022 | |
| Tactile Systems Technology INC | $21.45 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cydnee Parris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.